Shui-ping Gao
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Retraction: SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling.
Journal: Cancer research
Published: November 07, 2025
SNHG22 overexpression indicates poor prognosis and induces chemotherapy resistance via the miR-2467/Gal-1 signaling pathway in epithelial ovarian carcinoma.
Journal: Aging
Published: March 20, 2019
Downregulation of FOXP2 promotes breast cancer migration and invasion through TGFβ/SMAD signaling pathway.
Journal: Oncology letters
Published: November 29, 2017
High expression of COX5B is associated with poor prognosis in breast cancer.
Journal: Future oncology (London, England)
Published: June 09, 2017
Clinicopathological characteristics and survival outcomes of male breast cancer according to race: A SEER population-based study.
Journal: Oncotarget
Published: December 30, 2016
Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis.
Journal: Scientific reports
Published: November 08, 2016
Loss of TIM50 suppresses proliferation and induces apoptosis in breast cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: July 07, 2015
RETRACTED: SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling.
Journal: Cancer research
Published: June 17, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026